DOCSLIB.ORG

17Th International Congress of Pediatric Pulmonology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

PEDIATRIC PULMONOLOGY PEDIATRIC ISSN 8755-6863 VOLUME 53, SUPPLEMENT 1, JUNE 2018 PEDIATRIC PULMONOLOGY Volume 53 • Supplement 1 • June 2018 Proceedings S3 Acknowledgment PEDIATRIC PULMONOLOGY S4 Foreword S5 Keynote Lecture S8 I. Plenary Sessions S22 II. Topic Sessions - Part 1 S79 III. ISAM Joint Session S86 IV. Young Investigator’s Oral Communications S93 V. Posters S171 Boehringer-Ingelheim Satellite Symposium S174 Index Volume 53, Supplement 1, June 2018 53, Supplement 1, June Volume S1 –S178 Pages 17th International Congress of Pediatric Pulmonology Toledo Spain, June 21–24 2018 ONLINE SUBMISSION AND PEER REVIEW http://mc.manuscriptcentral.com/ppul PEDIATRIC PULMONOLOGY PEDIATRIC ISSN 8755-6863 VOLUME 53, SUPPLEMENT 1, JUNE 2018 PEDIATRIC PULMONOLOGY Volume 53 • Supplement 1 • June 2018 Proceedings S3 Acknowledgment PEDIATRIC PULMONOLOGY S4 Foreword S5 Keynote Lecture S8 I. Plenary Sessions S22 II. Topic Sessions - Part 1 S79 III. ISAM Joint Session S86 IV. Young Investigator’s Oral Communications S93 V. Posters S171 Boehringer-Ingelheim Satellite Symposium S174 Index Volume 53, Supplement 1, June 2018 53, Supplement 1, June Volume S1 –S178 Pages 17th International Congress of Pediatric Pulmonology Toledo Spain, June 21–24 2018 ONLINE SUBMISSION AND PEER REVIEW http://mc.manuscriptcentral.com/ppul PEDIATRIC PULMONOLOGY Editor-in-Chief: THOMAS MURPHY, Watertown, MA USA Deputy Editor: TERRY NOAH, Chapel Hill, NC USA Associate Editors: ANNE CHANG, Brisbane, Queensland, Australia STEPHANIE DAVIS, Indianapolis, IN USA ALEXANDER MOELLER, Zurich, Switzerland KUNLING SHEN, Beijing, China PAUL STEWART, Chapel Hill, NC USA STEVEN TURNER, Aberdeen, Scotland, United Kingdom Topic Editors: JUDITH VOYNOW, Richmond, VA USA HEATHER ZAR, Cape Town, South Africa Managing Editor: MICHELLE BAYMAN, Hoboken, NJ USA Editorial Board Richard Auten Brigitte Fauroux Min Lu Jürgen Schwarze Durham, NC USA Paris, France Shanghai, China Edinburgh, Scotland Avi Avital Michael Fayon George B. Mallory, Jr. Hiran Selvadurai Bordeaux, France Houston, TX USA Jerusalem, Israel Sydney, Australia Ian Balfour-Lynn Shona Fielding Franc¸ois Marchal Aberdeen, Scotland Nancy, France Renato Stein London, UK Porto Alegre, Brazil Monika Gappa Susanna McColley Eugenio Baraldi Wesel, Germany Chicago, IL USA Mary Sunday Padova, Italy Ben Gaston Mark Montgomery Durham, NC USA Lea Bentur Cleveland, OH USA Calgary, AB Canada Haifa, Israel Masato Takase Robert P. Gie Thomas Nicolai Tokyo, Japan David Birnkrant Tygerberg, South Africa Munich, Germany Cleveland, OH USA Asher Tal David Gozal Cathy Owens Beer-Sheva, Israel Hans Bisgaard Chicago, IL, USA London, UK Copenhagen, Denmark Anne Greenough Stacey Peterson-Carmichael Alejandro Teper Frank J. Cerny London, UK Indianapolis, IN USA Buenos Aires, Argentina Buffalo, NY USA Matthias Griese Thomas A.E. Platts-Mills Dick Tibboel Ira Cheifetz Munich, Germany Charlottesville, VA USA Rotterdam, The Netherlands Durham, NC USA Zoltan Hantos Jean-Paul Praud Harm Tiddens Szeged, Hungary Sherbrooke, QC Canada Andrew A. Colin Rotterdam, The Netherlands Miami, FL USA Adam Jaffe Sarath Ranganathan Sydney, Australia Melbourne, Australia Goran Wennergren Cori Daines Goteborg, Sweden Tucson, AZ USA Benny Joyner Felix Ratjen Chapel Hill, NC USA Toronto, ON Canada Yong Hong Yang Shyamala Dakshinamurti Athanasios Kaditis Gregory J. Redding Beijing, China Winnipeg, MB Canada Athens, Greece Seattle, WA USA Ozge Yilmaz Jacques De Blic Jennifer Knight-Madden Clement Ren Manisa, Turkey Paris, France Kingston, Jamaica Indianapolis, IN USA Lisa Young Chris DeBoeck Anastassios Koumbourlis Bruce Rubin Boortmeerbeek, Belgium Washington, DC USA Richmond, VA USA Nashville, TN USA Elisabeth Dellon Richard Kravitz Francesca Santamaria Zhangsheng Yu Chapel Hill, NC USA Durham, NC USA Naples, Italy Indianapolis, IN USA Editors-in-Chief Emeritus Victor Chernick Winnipeg, MB Canada Gerd J.A. Cropp San Francisco, CA USA George Polgar Philadelphia, PA USA 1 © 2018 Wiley Periodicals, Inc. All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means without the prior permission in writing from the copyright holder. Authorization to copy items for internal and personal use is granted by the copyright holder for libraries and other users registered with their local Reproduction Rights Organization (RRO), e.g. Copyright Clearance Center (CCC), 222 Rosewood Drive, Danvers, MA 01923, USA (www.copyright.com), provided the appropriate fee is paid directly to the RRO. This consent does not extend to other kinds of copying such as copying for general distribution, for advertising or promotional purposes, for creating new collective works or for resale. Special requests should be addressed to: [email protected] Pediatric Pulmonology (Print ISSN 8755-6863; Online ISSN 1099-0496 at Wiley number in order to expedite handling. Missing copies will be supplied when losses Online Library, wileyonlinelibrary.com) is published monthly by Wiley Subscrip- have been sustained in transit and where reserve stock permits. Send claims in care tion Services, Inc., a Wiley Company, 111 River St., Hoboken, NJ 07030-5774. of John Wiley & Sons, Inc., Attn: Journals Admin Dept UK, 111 River Street, Hoboken, Periodical Postage Paid at Hoboken, NJ and additional offi ces. Postmaster: Send all NJ 07030. Cancellations: Subscription cancellations will not be accepted after the address changes to Pediatric Pulmonology, Journal Customer Services, John Wiley fi rst issue has been mailed. Delivery Terms and Legal Title: Where the subscription & Sons, 111 River Street, Hoboken, NJ 07030; (201) 748-8832. Send subscription price includes print issues and delivery is to the recipient’s address, delivery terms are inquiries in care of: John Wiley & Sons, Inc., Attn: Journals Admin, Dept UK, 111 Delivered Duty Unpaid (DDU); the recipient is responsible for paying any import duty River Street, Hoboken, NJ 07030. Advertising inquiries should be addressed to or taxes. Title to all issues transfers FOB our shipping point, freight prepaid. We will M.J. Mrvica and Associates, Inc., 2 West Taunton Avenue, Berlin, NJ 08009, (856) endeavour to fulfi ll claims for missing or damaged copies within six months of publica- 768-9360. Fax: (856) 753-0064. E-mail: [email protected]. Information for sub- tion, within our reasonable discretion and subject to availability. Submission Instruc- scribers: Pediatric Pulmonology is published in 12 issues per year. Institutional sub- tions, Subscription, and All Other Information: www.wileyonlinelibrary.com/access scription prices for 2017 are: Print and online: $4654 (US), (Europe), £2570 €3249 Wiley’s Corporate Citizenship initiative seeks to address the environmental, social, economic, (UK). Prices are exclusive of tax. Asia-Pacifi c GST, Canadian GST/HST and European and ethical challenges faced in our business and which are important to our diverse VAT will be applied at the appropriate rates. For more information on current tax rates, stakeholder groups. Since launching the initiative, we have focused on sharing our please go to www.wileyonlinelibrary.com/tax-vat. The price includes online access to the content with those in need, enhancing community philanthropy, reducing our carbon current and all online back fi les to January 1st 2014, where available. For other pric- impact, creating global guidelines and best practices for paper use, establishing a ven- ing options, including access information and terms and conditions, please visit dor code of ethics, and engaging our colleagues and other stakeholders in our efforts. www.wileyonlinelibrary.com/access. Follow our progress at www.wiley.com/go/citizenship Pediatric Pulmonology accepts articles for Open Access publication. Please visit Access to this journal is available free online within institutions in the developing http://olabout.wiley.com/WileyCDA/Section/id-406241.html for further information world through the HINARI initiative with the WHO. For information, visit www. about OnlineOpen. healthinternetwork.org Please direct production questions to [email protected] Disclaimer: The Publisher and Editors cannot be held responsible for errors or any Journal Customer Services: For ordering information, claims, and any enquiry consequences arising from the use of information contained in this journal; the views concerning your journal subscription please go to www.wileycustomerhelp.com/ask or and opinions expressed do not necessarily reflect those of the Publisher and Editors, contact your nearest offi ce. neither does the publication of advertisements constitute any endorsement by the Americas: Email: [email protected]; Tel:+ 1 781 388 8598 or + 1 800 835 6770 Publisher and Editors of the products advertised. (toll free in the USA & Canada). The Journal is indexed by: CAB Abstracts® (CABI), CINAHL: Cumulative Index to Europe, Middle East and Africa: Email: [email protected]; Tel: +44 (0) 1865 Nursing & Allied Health Literature (EBSCO), Current Contents®/Clinical Medicine 778315. (Thomson ISI), EMBASE/Excerpta Medica (Elsevier), Index Medicus/MEDLINE/ Asia Pacifi c: Email: [email protected]: Tel: +65 6511 8000. PubMed (NLM), Journal Citation Reports/Science Edition (Thomson ISI), PASCAL Japan: For Japanese speaking support, Email: [email protected]; Tel: +65 6511 8010 Database (INIST/ CNRS), Pulmonary Reviews (Jobson Medical Group), Reference or Tel (toll-free): 005 316 50 480. Update (Thomson ISI), Respiratory Reviews (Clinicians Group), Science Citation
Recommended publications
  • OM-85) on Frequency of Upper Respiratory Tract Infections and Size of Adenoid Tissue in Preschool Children with Adenoid Hypertrophy

    OM-85) on Frequency of Upper Respiratory Tract Infections and Size of Adenoid Tissue in Preschool Children with Adenoid Hypertrophy

    STUDY PROTOCOL Effect of Vaxoral® (OM-85) on frequency of upper respiratory tract infections and size of adenoid tissue in preschool children with adenoid hypertrophy Study Product(s) Vaxoral® (OM-85) Indication Recurrent RTIs, adenoid hypertrophy Sponsor Dr Sami Ulus Maternity and Children Research and Training Hospital, Department of Pediatric Allergy and Immunology, Ankara, TURKEY Anticipated Turkey Countries Introduction OM-85 significantly reduces RTIs in children. This effect was proved by many clinical studies and meta-analyses1. A Cochrane meta-analysis first published in 2006 and updated recently (Del- Rio-Navarro 2012) showed that immunostimulants (IS) could reduce acute RTIs (ARTIs) by almost 39% when compared to placebo. Among the different IS, OM-85 showed the most robust evidence with 4 trials of “A quality” according to the Cochrane grading criteria. Pooling six OM-85 studies, the Cochrane review reported a mean number of ARTIs reduction by -1.20 [95% CI: - 1.75, -0.66] and a percentage difference in ARTIs by -35.9% [95% CI: -49.46, -22.35] compared to placebo1. Adenoid hypertrophy (AH) is one of the most important respiratory disease in preschool children2. In normal conditions adenoid tissue enlarges up to 5 years and become smaller afterwards. But in some children who have recurrent URTIs, it keeps growing and this can be associated with complications2. AH may cause recurrent respiratory infections and each infection contributes to enlargement of adenoid tissue thus promoting a vicious cycle. Additionally enlarged adenoids are known to be reservoir for microbes and cause of recurrent or long lasting RTIs3. AH is associated with chronic cough, recurrent and chronic sinusitis, recurrent tonsillitis, recurrent otitis media with effusion, recurrent other respiratory problems such as, nasal obstruction and sleep disturbances, sleep apneas2-3.
  • Current Management and Outcome of Tracheobronchial Malacia and Stenosis Presenting to the Paediatric Intensive Care Unit

    Current Management and Outcome of Tracheobronchial Malacia and Stenosis Presenting to the Paediatric Intensive Care Unit

    Intensive Care Med 52001) 27: 722±729 DOI 10.1007/s001340000822 NEONATAL AND PEDIATRIC INTENSIVE CARE David P.Inwald Current management and outcome Derek Roebuck Martin J.Elliott of tracheobronchial malacia and stenosis Quen Mok presenting to the paediatric intensive care unit Abstract Objective: To identify fac- but was not related to any other fac- Received: 10 July 2000 Final Revision received: 14 Oktober 2000 tors associated with mortality and tor. Patients with stenosis required a Accepted: 24 October 2000 prolonged ventilatory requirements significantly longer period of venti- Published online: 16 February 2001 in patients admitted to our paediat- latory support 5median length of Springer-Verlag 2001 ric intensive care unit 5PICU) with ventilation 59 days) than patients tracheobronchial malacia and with malacia 539 days). stenosis diagnosed by dynamic con- Conclusions: Length of ventilation Dr Inwald was supported by the Medical Research Council. This work was jointly trast bronchograms. and bronchographic diagnosis did undertaken in Great Ormond Street Hos- Design: Retrospective review. not predict survival. The only factor pital for Children NHSTrust, which re- Setting: Tertiary paediatric intensive found to contribute significantly to ceived a proportion of its funding from the care unit. mortality was the presence of com- NHSExecutive; the views expressed in this Patients: Forty-eight cases admitted plex cardiac and/or syndromic pa- publication are those of the authors and not to our PICU over a 5-year period in thology. However, patients with necessarily those of the NHSexecutive. whom a diagnosis of tracheobron- stenosis required longer ventilatory chial malacia or stenosis was made support than patients with malacia.
  • The Role of Larygotracheal Reconstruction in the Management of Recurrent Croup in Patients with Subglottic Stenosis

    The Role of Larygotracheal Reconstruction in the Management of Recurrent Croup in Patients with Subglottic Stenosis

    International Journal of Pediatric Otorhinolaryngology 82 (2016) 78–80 Contents lists available at ScienceDirect International Journal of Pediatric Otorhinolaryngology jo urnal homepage: www.elsevier.com/locate/ijporl The role of larygotracheal reconstruction in the management of recurrent croup in patients with subglottic stenosis a,b,c, a,b a,d,e Bianca Siegel *, Prasad Thottam , Deepak Mehta a Department of Pediatric Otolaryngology, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA b Children’s Hospital of Michigan, Detroit, MI, USA c Wayne State University School of Medicine Department of Otolaryngology, Detroit, MI, USA d Texas Children’s Hospital, Houston, TX, USA e Baylor University School of Medicine Department of Otolaryngology, Houston, TX, USA A R T I C L E I N F O A B S T R A C T Article history: Objectives: To determine the role of laryngotracheal reconstruction for recurrent croup and evaluate Received 16 October 2015 surgical outcomes in this cohort of patients. Received in revised form 4 January 2016 Methods: Retrospective chart review at a tertiary care pediatric hospital. Accepted 6 January 2016 Results: Six patients who underwent laryngotracheal reconstruction (LTR) for recurrent croup with Available online 13 January 2016 underlying subglottic stenosis were identified through a search of our IRB-approved airway database. At the time of diagnostic bronchoscopy, all 6 patients had grade 2 subglottic stenosis. All patients were Keywords: treated for reflux and underwent esophageal biopsies at the time of diagnostic bronchoscopy; 1 patient Laryngotracheal reconstruction had eosinophilic esophagitis which was treated. All patients had a history of at least 3 episodes of croup Recurrent croup in a 1 year period requiring multiple hospital admissions.
  • Diagnostic Issues in Systemic Lupus Erythematosis

    Diagnostic Issues in Systemic Lupus Erythematosis

    266 Postgrad Med J 2001;77:266–285 Postgrad Med J: first published as 10.1136/pmj.77.906.268 on 1 April 2001. Downloaded from SELF ASSESSMENT QUESTIONS Diagnostic issues in systemic lupus erythematosis N Sofat, C Higgens Answers on p 274. A 24 year old woman was diagnosed with sys- (4) What other tests (apart from 24 hour urine temic lupus erythematosis (SLE) based on a creatinine clearance) are available to measure few months’ history of a photosensitive skin the glomerular filtration rate? rash, predominantly on her face, arthralgia The patient had a 24 hour urinary protein col- involving both hands and wrists, a positive lection, which showed a 24 hour protein measure- antinuclear antibody (ANA) test and a raised ment of 1.8 g. There was no evidence of cellular antinative double stranded DNA antibody casts on urine microscopy. Her blood results were binding level. She was treated with oral as below (normal values are in parentheses): hydroxychloroquine 400 mg daily and short x Sodium 134 mmol/l (135–145) courses of prednisolone during flare-ups. x Potassium 4.5 mmol/l (3.5–5.0) She was reviewed in clinic for her regular x Urea 7.0 mmol/l (2.5–6.7) follow up appointment when she was found to x Creatinine 173 µmol/l (70–115) be hypertensive on repeated measurements of x Haemoglobin 108 g/l (115–160) her blood pressure, an average value being x White cell count 4.5 × 109/l (4.0–11.0) 150/90 mm Hg. She was also urine dipstick x Platelets 130 × 109/l (150–400) positive for blood and protein.
  • Left Bronchial with Bronchomalacia, Intractable Wheeze

    Left Bronchial with Bronchomalacia, Intractable Wheeze

    Thorax 1991;46:459-461 459 heart disease.7 This report describes a boy Left bronchial who had had intractable wheezing from infancy as a result of widespread discrete areas isomerism associated of bronchomalacia without bronchiectasis, Thorax: first published as 10.1136/thx.46.6.459 on 1 June 1991. Downloaded from and who also had some minor congenital with bronchomalacia, malformations and a rare combination of bronchial, atrial, and abdominal anatomical presenting with arrangements. We report this case because of the unusual anatomy and other congenital intractable wheeze malformations, and to emphasise the care needed in assessing wheezy children. Philip Lee, Andrew Bush, John 0 Warner Case report This 12 year old boy was referred as a case of steroid resistant asthma. He had had recurrent episodes of coughing and noisy breathing from the age of 5 months, usually precipitated by an upper respiratory infection. At 22 months a Abstract murmur was noted during an episode of right The cause of the Williams Campbell syn- lower lobe pneumonia, and he subsequently drome (bronchomalacia with bronchi- underwent ligation ofa patent arterial duct. He ectasis) is controversial. A boy with subsequently developed wheezing in the early bronchomalacia, bifid ribs, and left bron- morning, a chronic cough, and breathlessness chial isomerism presented with intract- on minimal exertion, despite inhaling sal- able wheeze mimicking asthma. The butamol and beclomethasone. A trial of oral combination of the abdominal, bron- prednisolone, 30 mg daily for one week, failed chial, and atrial anatomy seen in this to improve his symptoms. The only physical child has been described only once finding of note was widespread inspiratory and previously.
  • Who's Who in Pulmonology

    Who's Who in Pulmonology

    WHO’S WHO Who’s who in pulmonology Prof. Heather Zar heads the Division of Paediatric Health Department, and Director of the School of Child and Pulmonology at Red Cross War Memorial Children’s Adolescent Health at RCWMCH. She is Director of the Medical Hospital (RCWMCH), University of Cape Town Research Council Unit on Child and Adolescent Health. Her work on (UCT), with Drs Marco Zampoli, Aneesa Vanker childhood respiratory diseases, including pneumonia, tuberculosis, and Diane Gray, sharing consultant responsibilities. asthma and HIV-associated lung diseases has been internationally It is a diverse unit, managing a wide range of recognised; she has published more than 250 peer-reviewed paediatric respiratory conditions, and has an active publications and has substantial international grant support. She training and research programme with trainees currently serves as President of the Pan African Thoracic Society and from both South Africa (SA) and the African continent. on the Forum of International Respiratory Societies. She received the Heather is also Professor and Head of the Paediatrics and Child World Lung Health Award in 2014. Dr Marco Zampoli completed his paediatric and the cystic fibrosis clinic and provides clinical oversight and leadership sub-specialist training at RCWMCH and UCT in for the Breatheasy programme at RCWMCH, which supports 2007. His clinical and research interests in the field of children on the tracheostomy and ventilation home-care programme. paediatric pulmonology are wide and include HIV- Dr Zampoli is the current chair of the SA Cystic Fibrosis Medical related lung disorders, cystic fibrosis, neuromuscular and Scientific Advisory Committee and treasurer of the South African diseases and sleep medicine.
  • Clinical Study Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children

    Clinical Study Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children

    Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 629607, 10 pages http://dx.doi.org/10.1155/2013/629607 Clinical Study Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children Anita Szalmás,1 Zoltán Papp,2 Péter Csomor,2 József Kónya,1 István Sziklai,2 Zoltán Szekanecz,3 and Tamás Karosi2 1 Department of Medical Microbiology, Medical and Health Science Center, University of Debrecen, Nagyerdei Krt. 98, Debrecen 4032, Hungary 2 Department of Otolaryngology and Head and Neck Surgery, Medical and Health Science Center, University of Debrecen, Nagyerdei Krt. 98, Debrecen 4032, Hungary 3 Department of Rheumatology, Medical and Health Science Center, University of Debrecen, Nagyerdei Krt. 98, Debrecen 4032, Hungary Correspondence should be addressed to Tamas´ Karosi; [email protected] Received 24 April 2013; Accepted 23 August 2013 Academic Editor: Ralph Mosges¨ Copyright © 2013 Anita Szalmas´ et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. Adenoid hypertrophy is a common condition in childhood, which may be associated with recurring acute otitis media (RAOM), otitis media with effusion (OME), and obstructive sleeppnea a syndrome (OSAS). These different clinical characteristics have some clinical overlap; however, they might be explained by distinct immunologic and infectious profiles and result in various histopathologic findings of adenoid specimens. Methods. A total of 59 children with adenoid hypertrophy undergoing adenoidectomy were studied. Three series of identical adenoid specimens were processed to hematoxylin-eosin (H.E.) and Gram staining and to respiratory virus specific real-time PCR, respectively.
  • Revision Tracheobronchoplasty: Case Report

    Revision Tracheobronchoplasty: Case Report

    4 Case Report Page 1 of 4 Revision tracheobronchoplasty: case report Ammara A. Watkins, Jennifer L. Wilson, Mihir Parikh, Adnan Majid, Sidhu P. Gangadharan Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess, Harvard Medical School, Boston, MA, USA Correspondence to: Sidhu P. Gangadharan, MD. Chief, Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, 185 Pilgrim Rd. W/DC 201 Boston, MA 02215, USA. Email: [email protected]. Abstract: Tracheobronchoplasty, or posterior splinting of the airway with mesh, is a durable solution for patients with severe tracheobronchomalacia (TBM). Recurrent symptoms of TBM following tracheobronchoplasty are uncommon; however, when they occur can have significant impact on quality of life. Appropriate management of recurrent TBM requires a systematic and multidisciplinary collaborative approach. We present a patient with postoperative symptom recurrence requiring revisional tracheobronchoplasty to highlight the complexity of the disease’s presentation, workup and treatment. Keywords: Reoperative; revision; tracheobronchoplasty; tracheobronchomalacia (TBM); case report Received: 06 October 2019; Accepted: 18 December 2019; Published: 25 November 2020. doi: 10.21037/ccts.2019.12.14 View this article at: http://dx.doi.org/10.21037/ccts.2019.12.14 Introduction her tracheobronchoplasty she reported recurrent wheezing, cough and shortness of breath. By four years following Tracheobronchomalacia is an increasingly recognized her operation, the progressive symptoms considerably abnormality of the central airway that can cause dyspnea, impacted her quality of life. She was unable to walk 2 cough, recurrent respiratory infections and respiratory blocks without shortness of breath and had been admitted insufficiency (1,2). The hallmark of the disease is expiratory at least six times in the past year due to respiratory distress.
  • [Intrinsic] Tracheomalacia in Children

    [Intrinsic] Tracheomalacia in Children

    Interventions for primary (intrinsic) tracheomalacia in children (Review) Masters IB, Chang AB This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2005, Issue 4 http://www.thecochranelibrary.com Interventions for primary (intrinsic) tracheomalacia in children (Review) Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 BACKGROUND .................................... 2 OBJECTIVES ..................................... 3 METHODS ...................................... 3 RESULTS....................................... 5 DISCUSSION ..................................... 5 AUTHORS’CONCLUSIONS . 6 ACKNOWLEDGEMENTS . 6 REFERENCES ..................................... 6 CHARACTERISTICSOFSTUDIES . 7 DATAANDANALYSES. 9 ADDITIONALTABLES. 9 WHAT’SNEW..................................... 9 HISTORY....................................... 10 CONTRIBUTIONSOFAUTHORS . 10 DECLARATIONSOFINTEREST . 10 SOURCESOFSUPPORT . 10 INDEXTERMS .................................... 10 Interventions for primary (intrinsic) tracheomalacia in children (Review) i Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Intervention Review] Interventions for primary (intrinsic) tracheomalacia in children I Brent Masters1, Anne B Chang2 1Respiratory Medicine, Royal Children’s Hospital, Brisbane, Australia.
  • Mediastinum and Subcutaneous Emphysema: a Rare Complication of a Common Procedure

    Mediastinum and Subcutaneous Emphysema: a Rare Complication of a Common Procedure

    Case Report Brunei Int Med J. 2017; 13 (1): 29-32 Post adenotonsillectomy pneumo- mediastinum and subcutaneous emphysema: A rare complication of a common procedure. Farah Wahida ABD MANAB1,2, Nor Shahida ABDUL MUTALLIB1, Hisham ABDUL RAH- MAN1, Hamidah MAMAT1 1Department of otorhinolaryngology-Head and Neck surgery, Hospital Sultan Abdul Halim, Kedah, Malaysia, 2Department of Otorhinolaryngology, Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia ABSTRACT Cervicofacial and pneumomediastinum subcutaneous emphysema is a very rare complication of adenotonsillectomy procedure. Even though it is a self limiting complication and can be treated conservatively, it can alarming for the patient or patient’s family as well as leading to more seri- ous and fatal consequences occurring from tension pneumomediastinum. We report a case of incidental finding of pneumomediastinum in postadenotonsillectomy patient. He was managed conservatively and made an uneventful recovery. Keywords: tonsillectomy, subcutaneous emphysema, complication INTRODUCTION Case Report Adenotonsillectomy is a common surgical pro- A 12 year old boy was admitted to our Ear, cedure among paediatric age group. It is rela- Nose and Throat (ENT) ward for elective sur- tively a safe procedure with minimal compli- gery of adenotonsillectomy. The indication for cations. Common complications are intraoper- surgery was recurrent attacks of acute tonsil- ative or postoperative haemorrhage, infec- litis. He had underlying Allergic Rhinitis and tion, damaged to soft tissue and surrounding Bronchial Asthma. structure such as teeth, odynophagia and oropharyngeal edema.1 Cervicofacial and Patient was given general anaesthesia with pneumomediastinum subcutaneous emphyse- fentanyl, propofol and cisatracium during in- ma is a very rare complication.
  • For Early Career Professionals

    For Early Career Professionals

    INTERNATIONAL CONFERENCE May 15-20, 2020 | Philadelphia, PA conference.thoracic.org 2020 ROAD MAP FOR EARLY CAREER PROFESSIONALS Philadelphia, PA May 15 - May 20, 2020 conference.thoracic.org AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE CONTENTS Welcome Letter ..........................................................................................................................3 Tips for First Time ATS Attendees ...........................................................................................4 Networking Exchange for Early Career Professionals .......................................................5 Road Map Schedule .................................................................................................................6 Important Events for Early Career Professionals ...............................................................11 The ATS at a Glance ................................................................................................................ 12 ATS Assembly Membership Meetings ................................................................................. 13 ATS Faculty Development Series ......................................................................................... 14 Center for Career Development Schedule of Events ........................................................ 15 Diversity Forum & Women’s Forum ...................................................................................... 16 BEAR Cage ..............................................................................................................................
  • 18Th International Congress of Pediatric

    18Th International Congress of Pediatric

    PEDIATRIC PULMONOLOGY PEDIATRIC ISSN 8755-6863 VOLUME 54 , SUPPLEMENT 1 , JUNE 2019 PEDIATRIC PULMONOLOGY Volume Volume 54 • Supplement 18th International Congress of Pediatric Pulmonology Tokyo Chiba, June 27 – 30, 2019 1 • June 2019 2019 June Pages S1–S156 S1–S156 ONLINE SUBMISSION AND PEER REVIEW http://mc.manuscriptcentral.com/ppul PEDIATRIC PULMONOLOGY Volume 54 • Supplement 1 • June 2019 Proceedings S5 Foreword S6 Keynote Lecture S7 Plenary Sessions S22 Topic Sessions S75 Young Inves gator’s Oral Communica ons S81 Poster Sessions S149 Symposium Satellite OM Pharma S152 Index PEDIATRIC PULMONOLOGY Editor-in-Chief: THOMAS MURPHY, Boston, MA USA Deputy Editor: TERRY NOAH, Chapel Hill, NC USA Associate Editors: RICHARD AUTEN, Chapel Hill, NC USA ANNE CHANG, Brisbane, Queensland, Australia STEPHANIE DAVIS, Chapel Hill, NC USA HENRY DORKIN, Boston, MA USA BEN GASTON, Cleveland, OH USA ALEXANDER MOELLER, Zurich, Switzerland CLEMENT REN, Indianapolis, IN USA KUNLING SHEN, Beijing, China RENATO STEIN, Porto Alegre, Brazil PAUL STEWART, Chapel Hill, NC USA STEVEN TURNER, Aberdeen, Scotland, United Kingdom Topic Editors: JUDITH VOYNOW, Richmond, VA USA HEATHER ZAR, Cape Town, South Africa Managing Editor: MICHELLE BAYMAN, Hoboken, NJ USA Editorial Board Steven Abman Michael Fayon Larry Lands Francesca Santamaria Denver, CO USA Bordeaux, France Montreal, Canada Naples, Italy Avi Avital Shona Fielding Min Lu Gregory Sawicki Jerusalem, Israel Aberdeen, Scotland Shanghai, China Boston, MA USA Ian Balfour-Lynn Monika Gappa George B. Mallory, Jr.